Masuda Esteban 4
4 · RIGEL PHARMACEUTICALS INC · Filed Mar 22, 2019
Insider Transaction Report
Form 4
Masuda Esteban
Sr. VP Research
Transactions
- Award
Employee Stock Option (right to buy)
2019-03-20+62,500→ 62,500 totalExercise: $4.49Exp: 2028-01-24→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]On January 24, 2018, the reporting person was granted a performance based option to purchase 62,500 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met.